Artiva Biotherapeutics, Inc.

NasdaqGM:ARTV Stock Report

Market Cap: US$264.1m

Artiva Biotherapeutics Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Fred Aslan

Chief executive officer

US$1.1m

Total compensation

CEO salary percentage52.8%
CEO tenure3.8yrs
CEO ownershipn/a
Management average tenure2.1yrs
Board average tenure4.1yrs

Recent management updates

Recent updates

Artiva: Natural Killer Cell Biotech With 1st Half Of 2025 Lupus Treatment Data

Jul 22

CEO Compensation Analysis

How has Fred Aslan's remuneration changed compared to Artiva Biotherapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$61m

Jun 30 2024n/an/a

-US$33m

Mar 31 2024n/an/a

-US$26m

Dec 31 2023US$1mUS$584k

-US$29m

Mar 31 2023n/an/a

-US$63m

Dec 31 2022n/an/a

-US$59m

Mar 31 2022n/an/a

-US$41m

Dec 31 2021US$3mUS$480k

-US$72m

Compensation vs Market: Fred's total compensation ($USD1.11M) is about average for companies of similar size in the US market ($USD1.47M).

Compensation vs Earnings: Fred's compensation has been consistent with company performance over the past year.

CEO

Fred Aslan (49 yo)

3.8yrs

Tenure

US$1,107,767

Compensation

Dr. Fred Aslan, M.D. is Founder of Adavium Medical, Inc. and serves as its Director. Dr. Aslan serves as President, Chief Executive Officer and Director at Artiva Biotherapeutics, Inc. since January 2021....

Leadership Team

NamePositionTenureCompensationOwnership
Fred Aslan
President3.8yrsUS$1.11mno data
Peter Flynn
Co-Founder & Strategic Advisorno dataUS$762.47k0.16%
$ 433.9k
Jennifer Bush
Executive VP4.2yrsUS$725.83k0.094%
$ 247.9k
Christopher Horan
Chief Technical Operations Officer2.9yrsUS$726.90k0%
$ 0
Neha Krishnamohan
CFO & Executive VP of Corporate Developmentless than a yearno datano data
Thorsten Graef
Chief Medical Officer2.4yrsno datano data
Heather Raymon
Senior Vice President of Research & Early Development1.8yrsno datano data
Javier Coindreau
Senior VP of Medical Affairsless than a yearno datano data
David Moriarty
Senior VP of Clinical Operationsless than a yearno datano data

2.1yrs

Average Tenure

49yo

Average Age

Experienced Management: ARTV's management team is considered experienced (2.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Fred Aslan
President3.8yrsUS$1.11mno data
Peter Flynn
Co-Founder & Strategic Advisorno dataUS$762.47k0.16%
$ 433.9k
Elizabeth Hougen
Independent Director3.6yrsUS$70.82k0%
$ 0
Richard Maziarz
Advisorno datano datano data
Kenneth Kalunian
Advisorno datano datano data
Jill Buyon
Advisorno datano datano data
Brian Daniels
Independent Chairman of the Board4.4yrsno datano data
Yong-Jun Huh
Director5.2yrsno datano data
Brad Rovin
Advisorno datano datano data
Maureen McMahon
Advisorno datano datano data
Laura Stoppel
Independent Director4.4yrsno datano data
Laura Bessen
Independent Director2.7yrsUS$46.82k0%
$ 0

4.1yrs

Average Tenure

50yo

Average Age

Experienced Board: ARTV's board of directors are considered experienced (4.1 years average tenure).